Collection's Items (Sorted by Submit Date in Descending order): 1821 to 1840 of 2762
| Title | Author(s) | Issue date | ???itemlist.??? |
| Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein | Tsoukatos, D. C.; Liapikos, T. A.; Tselepis, A. D.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Platelet-activating factor bio-system in human arteries | Tsoukatos, D. C.; Brocheriou, I.; Ninio, E.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Siminelakis, S. | 24-Nov-2015 | - |
| Platelet-activating factor and oxidized LDL | Androulakis, N.; Aronis, P.; Tsoukatos, D. C. | 24-Nov-2015 | - |
| Platelet-Activating-Factor Formation during Oxidative Modification of Low-Density-Lipoprotein When Paf-Acetylhydrolase Has Been Inactivated | Liapikos, T. A.; Antonopoulou, S.; Karabina, S. A. P.; Tsoukatos, D. C.; Demopoulos, C. A.; Tselepis, A. D. | 24-Nov-2015 | - |
| Platelet-Activating Factor (Paf) Bioactivity Formation and Lyso-Paf Accumulation in Human Arteries | Tsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S. | 24-Nov-2015 | - |
| Platelet Response to the Aggregatory Effect of Platelet-Activating-Factor (Paf) Exvivo in Patients with Acute Myocardial-Infarction | Tselepis, A. D.; Tsoukatos, D.; Droudes, C.; Donas, A.; Evangelou, A. | 24-Nov-2015 | - |
| Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery | Tsoukatos, D. C.; Brocheriou, I.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Ninio, E.; Siminelakis, S. | 24-Nov-2015 | - |
| Platelet-activating factor (PAF) and PAF-acetylhydrolase activity are secreted from human platelets mainly associated with platelet derived microparticles | Mitsios, J. V.; Tsironis, L. D.; Tselepis, A. D. | 24-Nov-2015 | - |
| Alkene epoxidation catalysed by binuclear manganese complexes | Louloudi, M.; Kolokytha, C.; Hadjiliadis, N. | 24-Nov-2015 | - |
| [3+2] cycloaddition of phenyliodonium bis(arylsulfonyl)methylides with alpha,beta-enones | Adam, W.; Gogonas, E. P.; Nyxas, L. A.; Hadjiarapoglou, L. P. | 24-Nov-2015 | - |
| Platelet derived microparticles inhibit Cu2+-induced LDL oxidation | Mitsios, J. V.; Lourida, E. S.; Papavasiliou, E. C.; Tselepis, A. D. | 24-Nov-2015 | - |
| Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes | Michalis, L. K.; Tambaki, A. P.; Katsouras, C. S.; Goudevenos, J. A.; Kolettis, T.; Adamidis, K.; Tselepis, A. D.; Sideris, D. A. | 24-Nov-2015 | - |
| Platelet Aggregability to Platelet-Activating-Factor at Rest and after Exercise in Patients with Coronary-Artery Disease | Goudevenos, J.; Tselepis, A. D.; Tsoukatos, D.; Grekas, G.; Kritikakos, J.; Sideris, D. | 24-Nov-2015 | - |
| Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy | Tselepis, A. D.; Goudevenos, J. A.; Tambaki, A. P.; Michalis, L.; Stroumbis, C. S.; Tsoukatos, D. C.; Elisaf, M.; Sideris, D. A. | 24-Nov-2015 | - |
| Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic Profile | Filippatos, T.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S. | 24-Nov-2015 | - |
| Plasma PAF-acetylhydrolase(Lp-PLA(2)) activity as a marker of small-dense LDL in subjects at median cardiovascular risk | Filippatos, T. D.; Gazi, I.; Kiortsis, D. N.; Elisaf, M. S.; Tselepis, A. D. | 24-Nov-2015 | - |
| Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemia | Tsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with beta-thalassemia | Tselepis, A. D.; Hahalis, G.; Tellis, C. C.; Papavasiliou, E. C.; Mylona, P. T.; Kourakli, A.; Alexopoulos, D. C. | 24-Nov-2015 | - |
| Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures | Milionis, H. J.; Elisaf, M. S.; Karabina, S. A. P.; Bairaktari, E.; Tselepis, A. D.; Siamopoulos, K. C. | 24-Nov-2015 | - |
| Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles | Tsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M. | 24-Nov-2015 | - |
